Next Generation Sequencing (NGS) Panels

Our NGS panel portfolio tests for a wide selection of hereditary genetic conditions. They offer a fast, thorough, and cost-effective diagnostic tool for patients with distinctive clinical features.

Order a test  Our specialized NGS Panels

A Targeted Approach for Testing Genetic Disorders

By streamlining our NGS panels to reflect the fast-growing knowledge of complex gene-disease associations, CENTOGENE’s NGS Panels represent start-of-the-art research – providing fast, thorough, and cost-effective diagnostic solutions for patients and their families.

Diagnosing a genetic disorder often requires analyzing multiple genes. We have designed our NGS panels to simultaneously test multiple genes associated with a particular disorder or group of disorders. Additionally, our panels include all relevant pathogenic and likely pathogenic variants (class 1 and class 2) within coding regions, regulatory sequences, and deep intronic regions. We use all publicly available databases such as HGMD and unpublished variants included in our rare disease-centric Bio/Databank to establish a diagnosis. We provide high-quality sequencing and best-in-class data analysis - interpreted and communicated in comprehensive medical reports. 

When choosing one of our NGS panels, your patients will receive high-quality sequencing, best-in-class data analysis and interpretation as well as comprehensive medical reports – significantly simplifying the diagnostic process for you and your patients.

Why Choose our NGS Panels?

Easy sample submission with CentoCard®

High quality clinical interpretation powered by CENTOGENE's rare disease-centric Bio/Databank

Quick turnaround time and the strictest quality criteria

User-friendly, online ordering and tracking with CentoPortal®

Our NGS Panels

NGS Panels are recommended for patients meeting any or multiple of the following criteria:*

  • Distinctive clinical features  
  • Family history of a particular disorder 
  • Multiple genes linked to condition  
  • Genetically heterogeneous disorders 
  • Well-defined disease-associated genes 

* Genet Med. 2015 Jun;17(6):444-51. doi: 10.1038/gim.2014.122. Epub 2

Conclusive Clinical Reports

  • Interpretation of data by experienced professionals  
  • Clear results of identified variants following international best-practice guidelines (ACMG and CMSS) 
  • Detailed method description 
  • References to publications supporting medical and scientific results 
  • Recommendations for follow-up analyses for specific diseases 
  • Reporting of pathogenic variants, likely pathogenic variants and VUS

Medical Reporting

Pathogenic and likely pathogenic variants are reported following ACMG classification guidelines. Variants of uncertain significance (VUS) are not reported in any of the following cases: the described phenotype(s) is explained by detected pathogenic or likely pathogenic variant(s); the detected VUS are not related to the described phenotype(s) of the patient or family members; in the lack of sufficient clinical information; and in our oncogenetic panels.

Please note that detailed and specific clinical information (preferentially phenotype/HPOs) is required for variant interpretation and medical diagnosis.

Resources

Downloads

Panel Overview

NGS Panels Product Sheet

NGS Panels – Product Sheet

A targeted approach for testing genetic disorders

CENTOGENE NGS Panel Brochureposter English PDF

NGS Panels

Benefit from our medical expertise and streamlined genetic testing

CENTOGENE NGS Panels Handbook English PDF

NGS Panels – Handbook

A targeted approach for testing genetic disorders

Latest Webinars

Salud Reproductiva y Diagnóstico Genético Prenatal

A lo largo del CentoTalk, Pilar Gutibonza, MD, proporciona una descripción detallada de las opciones de detección prenatal de CENTOGENE y cómo las pruebas prenatales juegan un papel esencial.

Loading...

Reproductive Health and Prenatal Genetic Testing

Throughout the CentoTalk, Clarice Loh provides a detailed overview of CENTOGENE’s prenatal screening options and how prenatal testing plays an essential role in facilitating early answers when […]

Loading...

How Biomarkers Transform Genetic Diagnostics: A Success Story With Fabry Disease

Throughout the on demand CentoTalk, Dr. Tobias Boettcher provides an overview of how biomarkers play an essential role in early diagnosis, prediction, and therapeutic monitoring for Fabry disease […]

Loading...

CentoCard® – As Easy as Mailing a Letter

Dried blood spot (DBS) cards for patients’ samples collection and shipment. The simplest way to ship biological samples, making genetic testing available anywhere in the world.

Order CentoCard

CENTOGENE CentoCard Logo
CENTOGENE Woman with Tablet

Sample Requirements

CENTOGENE accepts many different types of samples for NGS Panel tests. Please refer to our dedicated Sample Requirements page for details.

Sample requirements

Transparency and Quality of Medical Reports

High-quality medical reporting is essential for building a partnership of trust.
 

Medical reporting

Get in Touch With Our Customer Support

Our consultation service is available in several languages.

+49 (0) 381 80 113 - 416

Mon. – Fri. 7 a.m. – 8 p.m. CEST

Sat. 8 a.m. – 12 p.m. CEST

Contact Us

For our US Partners:

+1 (617) 580 - 2102

Mon. – Fri. 9 a.m. – 5:30 p.m. EST


Contact Us